Measurement of subclinical atherosclerosis: beyond risk factor assessment

被引:30
|
作者
Bisoendial, RJ
Hovingh, GK
de Groot, E
Kastelein, JJP
Lansberg, PJ
Stroes, ESG
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Core Lab Cardiovasc Imaging, NL-1105 AZ Amsterdam, Netherlands
关键词
subclinical atherosclerosis; surrogate end-points; prevention; cardiovascular disease; risk factor management;
D O I
10.1097/00041433-200212000-00002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Assessment of subclinical atherosclerosis using the current available noninvasive imaging modalities holds promise for individual cardiovascular risk management and monitoring efficacy of therapeutic interventions (i.e. surrogate end-points). The present review addresses benefits and limitations of flow-mediated dilatation, intima-media thickness, electron-beam computed tomography and magnetic resonance coronary angiography. Recent findings Both carotid intima-media thickness and peripheral flow-mediated dilatation correlate inversely with cardiovascular risk factors and coronary artery disease. They have been shown to carry predictive value for future cardiovascular events, but clinical application of both intima-media thickness and flow-mediated dilatation demands further methodological maturation of these techniques. Intima thickening has been successfully targeted in numerous intervention trials, but determination of an explicit threshold value beyond which cardiovascular risk significantly increases will facilitate its utility as a routine clinical tool. Electron-beam computed tomography can accurately detect and quantify coronary artery calcification (an established marker of the total coronary plaque burden). However, lack of evidence of its additional predictive power for future coronary events warrants for further research. Finally, magnetic resonance coronary angiography appears to be a promising technique, integrating both functional and anatomical aspects of coronary artery disease. Properly designed studies are needed to determine its value in clinical practice. Summary Various noninvasive imaging techniques have recently emerged that may find applications in clinical research. However, before widespread clinical utilization, further technical refinement of all of the cited imaging modalities is mandatory. It will be a challenge over the coming few years to clarify whether improvements in surrogate end-points can directly be translated into improved outcomes.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 50 条
  • [1] Risk factors of subclinical atherosclerosis beyond cholesterol
    Toth, Stefan
    Toth, Timea
    Hertelyova, Zdenka
    Putrya, Alina
    Dvoroznakova, Marianna
    Pella, Daniel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 157 - 158
  • [2] Assessment of subclinical atherosclerosis and cardiovascular risk
    Benitez, RM
    Vogel, RA
    CLINICAL CARDIOLOGY, 2001, 24 (10) : 642 - 650
  • [3] Global risk factor assessment markedly underestimates subclinical atherosclerosis risk in asymptomatic women
    Nasir, K
    Rumberger, JA
    Braunstein, JB
    Michos, ED
    Budoff, MJ
    Blumenthal, RS
    CIRCULATION, 2004, 110 (17) : 790 - 791
  • [4] Subclinical atherosclerosis as a risk factor of cardiovascular events
    Boytsov, S. A.
    Kukharchuk, V. V.
    Karpov, Yu. A.
    Sergienko, I., V
    Drapkina, O. M.
    Semenova, A. E.
    Urazalina, S. Zh
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (03): : 82 - 86
  • [5] Prediabetes is not a risk factor for subclinical coronary atherosclerosis
    Park, Gyung-Min
    Cho, Young-Rak
    Lee, Seung-Whan
    Yun, Sung-Cheol
    Won, Ki-Bum
    Ann, Soe Hee
    Kim, Yong-Giun
    Kim, Shin-Jae
    Roh, Jae-Hyung
    Kim, Young-Hak
    Yang, Dong Hyun
    Kang, Joon-Won
    Lim, Tae-Hwan
    Jung, Chang Hee
    Koh, Eun Hee
    Lee, Woo Je
    Kim, Min-Seon
    Lee, Ki-Up
    Park, Joong-Yeol
    Kim, Hong-Kyu
    Choe, Jaewon
    Lee, Sang-Gon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 479 - 484
  • [6] Subclinical hypothyroidism as a new risk factor for coronary atherosclerosis
    Baranova, E. I.
    Volkova, A.
    Berkovich, O. A.
    Dora, S. V.
    Dygun, O. D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 771 - 771
  • [7] Diabetes is a risk factor for subclinical coronary atherosclerosis, but not prediabetes
    Kim, D. W.
    Park, G. M.
    Kim, T. S.
    Kim, C. J.
    Cho, J. S.
    Park, M. W.
    Her, S. H.
    Kwon, J. B.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1000 - 1001
  • [8] IS FATTY LIVER AN INDEPENDENT RISK FACTOR FOR SUBCLINICAL ATHEROSCLEROSIS?
    Di Costanzo, A.
    D'Erasmo, L.
    Polimeni, L.
    Loffredo, L.
    Coletta, P.
    Del Ben, M.
    Angelico, F.
    Montali, A.
    Girelli, G.
    De Masi, B.
    Maranghi, M.
    Arca, M.
    ATHEROSCLEROSIS, 2015, 241 (01) : E4 - E4
  • [9] Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism
    Reich, L. M.
    Folsom, A. R.
    Key, N. S.
    Boland, L. . L. .
    Heckbert, S. R.
    Rosamond, W. D.
    Cushman, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) : 1909 - 1913
  • [10] Insulin resistance as a risk factor for subclinical atherosclerosis in rheumatoid arthritis
    El Sayed, Adel Mahmoud
    El Bakry, Samah A.
    Mobasher, Sameh Abdelmotteleb
    Abd El Rahman, Rehab
    Abo-Shady, Rania Ahmed
    Abaza, Nouran
    EGYPTIAN RHEUMATOLOGIST, 2014, 36 (01): : 7 - 13